| P50 | author | Jennifer Keiser | Q21263002 |
| | Gordana Panic | Q55182161 |
| | Urs Duthaler | Q55187802 |
| | Benjamin Speich | Q50286527 |
| P2860 | cites work | Efficacy and safety of nitazoxanide, albendazole, and nitazoxanide-albendazole against Trichuris trichiura infection: a randomized controlled trial | Q21144496 |
| | Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis | Q21198915 |
| | Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis | Q21560762 |
| | Artemisinins and synthetic trioxolanes in the treatment of helminth infections | Q22061831 |
| | Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy | Q24615049 |
| | Evaluation of the in vivo activity of tribendimidine against Schistosoma mansoni, Fasciola hepatica, Clonorchis sinensis, and Opisthorchis viverrini | Q24670209 |
| | Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria | Q25256957 |
| | Drug repurposing and human parasitic protozoan diseases | Q26999453 |
| | Potential drug development candidates for human soil-transmitted helminthiases | Q27306274 |
| | Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening | Q27306843 |
| | Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 | Q27860791 |
| | Cyclooctadepsipeptides--an anthelmintically active class of compounds exhibiting a novel mode of action | Q28185384 |
| | Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections | Q28236279 |
| | Successful treatment of niclosamide- and praziquantel-resistant beef tapeworm infection with nitazoxanide | Q28254869 |
| | Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis | Q28271849 |
| | Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis | Q28277486 |
| | Filariasis: Current status, treatment and recent advances in drug development | Q37869168 |
| | Drug repositioning: re-investigating existing drugs for new therapeutic indications | Q37886513 |
| | Progress and challenges in the discovery of macrofilaricidal drugs | Q37912232 |
| | Antimalarials in the treatment of schistosomiasis. | Q38011217 |
| | Nematode infections: soil-transmitted helminths and trichinella | Q38013263 |
| | Nematode infections: filariases | Q38013264 |
| | Anticancer mechanisms and clinical application of alkylphospholipids | Q38058582 |
| | Advances in the discovery and development of trematocidal drugs | Q38089167 |
| | Analytical profile of moxidectin | Q38106293 |
| | Strongyloides stercoralis infection. | Q38125391 |
| | Diagnosis and treatment of schistosomiasis in children in the era of intensified control | Q38152776 |
| | Artemisinins: pharmacological actions beyond anti-malarial | Q38169463 |
| | The drug and vaccine landscape for neglected diseases (2000-11): a systematic assessment | Q38238051 |
| | Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial | Q38374795 |
| | Miltefosine, a promising novel agent for schistosomiasis mansoni | Q38983643 |
| | Trichuris trichiura infection and cognitive function in Jamaican school children. | Q39017766 |
| | Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms | Q39070559 |
| | Activity of tribendimidine and praziquantel combination therapy against the liver fluke Opisthorchis viverrini in vitro and in vivo | Q39126543 |
| | Efficacy, safety and pharmacokinetics of 1,2,4-trioxolane OZ78 against an experimental infection with Fasciola hepatica in sheep | Q39126591 |
| | Anthelmintic activity of artesunate against Fasciola hepatica in naturally infected sheep | Q39126608 |
| | Dose-response relationships and tegumental surface alterations in Opisthorchis viverrini following treatment with mefloquine in vivo and in vitro | Q39126638 |
| | Efficacy and safety of artemether against a natural Fasciola hepatica infection in sheep | Q39126668 |
| | Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica | Q39126701 |
| | Effect of artesunate and artemether against Clonorchis sinensis and Opisthorchis viverrini in rodent models | Q39126708 |
| | Artesunate and artemether are effective fasciolicides in the rat model and in vitro | Q39126714 |
| | The synthetic peroxide OZ78 is effective against Echinostoma caproni and Fasciola hepatica | Q39126725 |
| | Dihydroartemisinin: a new story of an old drug against Schistosoma mansoni infection | Q39175318 |
| | Therapeutic evaluation of oxantel pamoate (1, 4, 5, 6-tetrahydro-1-methyl-2-[trans-3-hydroxystyryl] pyrimidine pamoate) in severe Trichuris trichiura infection. | Q39219280 |
| | Efficacy and pharmacokinetics of OZ78 and MT04 against a natural infection with Fasciola hepatica in sheep | Q39242219 |
| | Lack of resistance after re-exposure of cattle cured of Onchocerca ochengi infection with oxytetracycline. | Q39301111 |
| | Effects of Ivermectin with and without doxycycline on clinical symptoms of onchocerciasis | Q39308899 |
| | Effect of a novel benzimidazole derivative in experimental Schistosoma mansoni infection. | Q39338872 |
| | Oxantel pamoate-albendazole for Trichuris trichiura infection | Q39482467 |
| | Prevalence of intestinal protozoa infection among school-aged children on Pemba Island, Tanzania, and effect of single-dose albendazole, nitazoxanide and albendazole-nitazoxanide | Q39482474 |
| | Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial | Q39515565 |
| | Flubendazole and mebendazole in the treatment of trichuriasis and other helminthiases | Q71082286 |
| | The anthelmintic effects of flubendazole on Trichuris trichiura and Ascaris lumbricoides | Q71157410 |
| | Nitazoxanide in the treatment of Taenia saginata and Hymenolepis nana infections | Q71380800 |
| | Guidelines for treatment of cystic and alveolar echinococcosis in humans. WHO Informal Working Group on Echinococcosis | Q71493332 |
| | Murine strongyloidiasis: The effects of Cyclosporin A and Thiabendazole administered singly and in combination | Q71959477 |
| | A role for 17-beta-estradiol in immunoendocrine regulation of murine cysticercosis (Taenia crassiceps) | Q72137367 |
| | A new therapeutic approach for the treatment of cystic echinococcosis: percutaneous albendazole sulphoxide injection without reaspiration | Q73363106 |
| | [Anthelmintic Effects Of Single Doses Of Fenbendazole And Oxantel-Pyrantel Pamoate To The Intestinal Nematodes] | Q73766044 |
| | Filaricidal efficacy of anthelmintically active cyclodepsipeptides | Q74608534 |
| | Albendazole plus praziquantel versus albendazole alone as a pre-operative treatment in intra-abdominal hydatisosis caused by Echinococcus granulosus | Q74765009 |
| | Ricobendazole kinetics and availability following subcutaneous administration of a novel injectable formulation to calves | Q77399615 |
| | Efficacy of fenbendazole and milbemycin oxime for treating baboons (Papio cynocephalus anubis) infected with Trichuris trichiura | Q79892995 |
| | Efficacy of co-administered diethylcarbamazine and albendazole against adult Wuchereria bancrofti | Q79965467 |
| | The efficacy of antihelminthic compound; Clorsulon against experimental Schistosoma mansoni infection | Q80503102 |
| | Trematode infections: liver and lung flukes | Q84221598 |
| | Global programme to eliminate lymphatic filariasis | Q84790179 |
| | Oxfendazole flukicidal activity in pigs | Q87638626 |
| | Soil-transmitted helminthiases: number of children treated in 2010 | Q95491318 |
| | Preventive chemotherapy: planning, requesting medicines, and reporting | Q95578463 |
| | Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial | Q28299316 |
| | Strongyloides ratti: in vitro and in vivo activity of tribendimidine | Q28472103 |
| | Evaluation of oxfendazole, praziquantel and albendazole against cystic echinococcosis: a randomized clinical trial in naturally infected sheep | Q28472998 |
| | Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis and Taenia spp.: open-label randomized trial | Q28473776 |
| | Community-directed delivery of doxycycline for the treatment of onchocerciasis in areas of co-endemicity with loiasis in Cameroon | Q28476179 |
| | Efficacy and safety of artemether in the treatment of chronic fascioliasis in Egypt: exploratory phase-2 trials | Q28476800 |
| | Randomized clinical trial on ivermectin versus thiabendazole for the treatment of strongyloidiasis | Q28479270 |
| | Activity of oxantel pamoate monotherapy and combination chemotherapy against Trichuris muris and hookworms: revival of an old drug | Q28488644 |
| | Open-source approaches for the repurposing of existing or failed candidate drugs: learning from and applying the lessons across diseases | Q28535314 |
| | Fascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanide | Q28535341 |
| | Orally active antischistosomal early leads identified from the open access malaria box | Q28538566 |
| | Efficacy of cyclooctadepsipeptides and aminophenylamidines against larval, immature and mature adult stages of a parasitologically characterized trichurosis model in mice | Q28539946 |
| | Macrofilaricidal activity after doxycycline only treatment of Onchocerca volvulus in an area of Loa loa co-endemicity: a randomized controlled trial | Q30481947 |
| | Finding new tricks for old drugs: an efficient route for public-sector drug discovery | Q33229063 |
| | Use of albendazole sulfoxide, albendazole sulfone, and combined solutions as scolicidal agents on hydatid cysts (in vitro study). | Q33396494 |
| | Clinical trial of Mirazid in treatment of human fascioliasis, Ezbet El-Bakly (Tamyia Center) Al-Fayoum Governorate | Q33432600 |
| | A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia | Q33693580 |
| | A Randomized, Single-Ascending-Dose, Ivermectin-Controlled, Double-Blind Study of Moxidectin in Onchocerca volvulus Infection | Q33812047 |
| | In-vivo activity of dihydroartemisinin against Schistosoma japonicum | Q33854942 |
| | Structure-activity relationship of an ozonide carboxylic acid (OZ78) against Fasciola hepatica | Q33899023 |
| | Efficacies of albendazole sulfoxide and albendazole sulfone against In vitro-cultivated Echinococcus multilocularis metacestodes | Q33976194 |
| | Strongyloidiasis--progress in diagnosis and treatment | Q34021710 |
| | Cestode infestations: hydatid disease and cysticercosis | Q34032078 |
| | Activity of antiandrogens against juvenile and adult Schistosoma mansoni in mice | Q34060384 |
| | The drugs we have and the drugs we need against major helminth infections | Q34125793 |
| | Comparative clinical studies of nitazoxanide, albendazole and praziquantel in the treatment of ascariasis, trichuriasis and hymenolepiasis in children from Peru | Q34132664 |
| | Combined androgen blockade for prostate cancer: Review of efficacy, safety and cost‐effectiveness | Q34150812 |
| | The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine | Q34223139 |
| | In vivo efficacy of the anthelmintic tribendimidine against the cestode Hymenolepis microstoma in a controlled laboratory trial | Q34226086 |
| | A review on the toxicity and non-target effects of macrocyclic lactones in terrestrial and aquatic environments | Q34228950 |
| | Exploring flubendazole formulations for use in sheep. Pharmacokinetic evaluation of a cyclodextrin-based solution | Q34284551 |
| | Advances with the Chinese anthelminthic drug tribendimidine in clinical trials and laboratory investigations. | Q34324579 |
| | Trematocidal activity of praziquantel and artemisinin derivatives: in vitro and in vivo investigations with adult Echinostoma caproni | Q34352275 |
| | Efficacy of milbemycin oxime against naturally acquired or experimentally induced Ancylostoma spp and Trichuris vulpis infections in dogs | Q52443770 |
| | [Experimental therapy in Chinese hamsters and rats infected with larval Echinococcus multilocularis by using mebendazole, albendazole and ivermectin with brief review of chemotherapy of human multilocular echinococcosis] | Q52462976 |
| | Efficacy of moxidectin against nematodes in naturally infected sheep. | Q52541893 |
| | A randomized trial of single- and two-dose ivermectin versus thiabendazole for treatment of strongyloidiasis. | Q52543470 |
| | Activity of doramectin against nematode endoparasites of cattle. | Q52544109 |
| | Evaluation of anthelmintic efficacy of doramectin against gastrointestinal nematodes by fecal examination in cattle in Japan. | Q52548869 |
| | Randomized, controlled, double-blind trial with ivermectin on Loa loa microfilaraemia: efficacy of a low dose (approximately 25 microg/kg) versus current standard dose (150 microg/kg). | Q52680155 |
| | Flubendazole: a candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs. | Q52721186 |
| | Piggy-backing the concept of cancer drugs for schistosomiasis treatment: a tangible perspective? | Q54646067 |
| | Tropical Diseases | Q56396076 |
| | Schistosomiasis | Q56639209 |
| | Praziquantel | Q56656935 |
| | COMPARISON OF FLUBENDAZOLE AND DIETHYLCARBAMAZINE IN TREATMENT OF ONCHOCERCIASIS | Q57245182 |
| | Effectiveness of single doses of Fenbendazole Hoe 88I against Ascaris, hookworm and Trichuris in man | Q67485462 |
| | [Comparison of efficacy of powder and tablet of mebendazole in the treatment of strongyloidiasis] | Q68012214 |
| | Treatment for trichuriasis with oxantel | Q68227584 |
| | Albendazole vs praziquantel for therapy for neurocysticercosis. A controlled trial | Q68320368 |
| | Fine-structure alterations in female Brugia malayi and Litomosoides carinii after in vivo treatment with flubendazole | Q68813924 |
| | Cyclosporine may eliminate the threat of overwhelming strongyloidiasis in immunosuppressed patients | Q69990790 |
| | Niclosamide therapy for tapeworm infections | Q70068227 |
| | Chemotherapy with diethylcarbamazine and levamisole in Bancroftian filariasis | Q70250295 |
| | The chemotherapy of onchocerciasis VIII Levamisole and its combination with the benzimidazoles | Q70535978 |
| | Flubendazole in the treatment of Ascaris lumbricoides and Trichuris trichiura: a comparison of two different regimens with single-dose | Q70803449 |
| | Cutaneous cysticercosis treated with metrifonate | Q70862701 |
| | Antischistosomal effects of cyclosporin A | Q70930242 |
| | Brugia malayi: Effects of nitazoxanide and tizoxanide on adult worms and microfilariae of filarial nematodes | Q45885382 |
| | Efficacy of 2- and 4-week rifampicin treatment on the Wolbachia of Onchocerca volvulus | Q45885521 |
| | Effects of 6-week azithromycin treatment on the Wolbachia endobacteria of Onchocerca volvulus | Q45885617 |
| | Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti | Q45885752 |
| | No depletion of Wolbachia from Onchocerca volvulus after a short course of rifampin and/or azithromycin | Q45885798 |
| | Flubendazole in cystic echinococcosis therapy: pharmaco-parasitological evaluation in mice. | Q45921818 |
| | Field evaluation of the efficacy and safety of emodepside plus praziquantel tablets (Profender tablets for dogs) against naturally acquired nematode and cestode infections in dogs. | Q45941313 |
| | Efficacy of chlorhexidine gluconate during surgery for hydatid cyst | Q46087605 |
| | Efficacy of two cyclooctadepsipeptides, PF1022A and emodepside, against anthelmintic-resistant nematodes in sheep and cattle | Q46408769 |
| | Schistosoma japonicum-infected hamsters (Mesocricetus auratus) used as a model in experimental chemotherapy with praziquantel, artemether, and OZ compounds | Q46793864 |
| | Effect of ozonide OZ418 against Schistosoma japonicum harbored in mice | Q47872179 |
| | Effectiveness of synthetic trioxolane OZ78 against Schistosoma japonicum in mice and rabbits | Q47998506 |
| | Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis | Q49037899 |
| | Mepacrine therapy in niclosamide resistant taeniasis. | Q50506209 |
| | Doramectin efficacy against gastrointestinal nematodes in pigs. | Q50981583 |
| | Effect of the in vivo activity of dihydroartemisinin against Schistosoma mansoni infection in mice. | Q51400781 |
| | Chemotherapy of schistosomiasis: present and future | Q36891317 |
| | Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes | Q36976710 |
| | Onchocerciasis control: vision for the future from a Ghanian perspective | Q37090909 |
| | Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study | Q37157555 |
| | Targeted therapy for breast cancer prevention | Q37190825 |
| | Combination chemotherapy against Clonorchis sinensis: experiments with artemether, artesunate, OZ78, praziquantel, and tribendimidine in a rat model | Q37333162 |
| | Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination. | Q37390491 |
| | Schistosomiasis in African infants and preschool children: let them now be treated! | Q37427116 |
| | Praziquantel: neglected drug? Ineffective treatment? Or therapeutic choice in cystic hydatid disease? | Q37449595 |
| | Thiazolides: a new class of antiviral drugs | Q37481436 |
| | Imatinib activity on Schistosoma mansoni | Q37675128 |
| | Update on the diagnosis and treatment of food-borne trematode infections | Q37777592 |
| | A short review of the anthelmintic role of Mirazid | Q37827720 |
| | A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection. | Q39538761 |
| | Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial | Q39544958 |
| | Macrofilaricidal activity of oral flubendazole on Brugia pahangi | Q39551068 |
| | Comparative performances of flubendazole and albendazole in cystic echinococcosis: ex vivo activity, plasma/cyst disposition, and efficacy in infected mice | Q39658873 |
| | Effect of amphotericin B on larval growth of Echinococcus multilocularis | Q39740486 |
| | Metrifonate. Summary of toxicological and pharmacological information available | Q39779684 |
| | Taeniasis unresponsive to a single dose of niclosamide: case report of persistent infection with Taenia saginata and a review of therapy. | Q39791427 |
| | Cyclosporine: a new immunosuppressive agent for organ transplantation | Q40188861 |
| | Doxycycline treatment of Brugia malayi-infected persons reduces microfilaremia and adverse reactions after diethylcarbamazine and albendazole treatment | Q40421498 |
| | Evaluation of a new antihelminthic for trichuriasis, hookworm, and stronglyloidiasis | Q41085302 |
| | In vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis | Q42272747 |
| | Effect of albendazole sulfoxide solution on the scolices and the hepatobiliary system | Q42537887 |
| | ACTs for schistosomiasis: do they act? | Q42939145 |
| | Effectiveness of mefloquine against Clonorchis sinensis in rats and Paragonimus westermani in dogs | Q42948723 |
| | Differential effects of ketoconazole and primaquine on the pharmacokinetics and tissue distribution of imatinib in mice. | Q42970920 |
| | In vitro activities of itraconazole, methiazole, and nitazoxanide versus Echinococcus multilocularis larvae | Q43152059 |
| | Imatinib has a fatal impact on morphology, pairing stability and survival of adult Schistosoma mansoni in vitro | Q43165015 |
| | Hydatid disease in acute leukemia: effect of anticancer treatment on echinococcosis | Q43218976 |
| | Tamoxifen treatment in hamsters induces protection during taeniosis by Taenia solium | Q43233965 |
| | Mirazid shows insignificant activity against ovine fascioliasis | Q43262443 |
| | Macrofilaricidal activity and amelioration of lymphatic pathology in bancroftian filariasis after 3 weeks of doxycycline followed by single-dose diethylcarbamazine | Q43264843 |
| | The in vitro and in vivo effect of tribendimidine and its metabolites against Clonorchis sinensis | Q43298552 |
| | Endectocidal efficacies of doramectin in naturally parasitized pigs | Q43408915 |
| | Clinical trial of flubendazole on hookworm, Trichuris trichiura and Ascaris lumbricoides infections | Q43517315 |
| | Tamoxifen treatment induces protection in murine cysticercosis. | Q43544298 |
| | Treatment of Taenia saginata and Hymenolepis nana infections with paromomycin | Q43797090 |
| | A comparative study of the effect of oxantel-pyrantel suspension and mebendazole in mixed infections with Ascaris and Trichuris | Q44011830 |
| | Dose confirmation studies of moxidectin 1% non-aqueous injectable and moxidectin 0.5% pour-on formulations against experimentally induced infections of larval and adult stage Oesophagostomum radiatum and Trichuris discolor in cattle | Q44111595 |
| | Discovering and developing new medicines for malaria control and elimination | Q44140279 |
| | Therapeutic and persistent efficacy of moxidectin 1% nonaqueous injectable formulation against natural and experimentally induced lung and gastrointestinal nematodes in cattle | Q44195919 |
| | Double-blind, randomized, placebo-controlled study of nitazoxanide in the treatment of fascioliasis in adults and children from northern Peru | Q44282413 |
| | Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections | Q44295428 |
| | Therapy for neurocysticercosis. Comparison between albendazole and praziquantel | Q44510087 |
| | Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico | Q44521827 |
| | Field studies on endoparasites of Thoroughbred foals on seven farms in central Kentucky in 2004. | Q44549154 |
| | The efficacy of two anthelmintics against ascarids and hookworms in naturally infected cats | Q44556366 |
| | The antiparasitic moxidectin: safety, tolerability, and pharmacokinetics in humans | Q44601138 |
| | The effect of metronidazole in treating human fascioliasis | Q44605444 |
| | Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity | Q44829961 |
| | Therapeutic effectiveness of fenbendazole (HOE-881) in helminthiasis transmited by the soil in the state of Chiapas, Mexico | Q44853720 |
| | Efficacy of moxidectin 0.5% pour-on against swine nematodes | Q44933495 |
| | In vitro effects of nitazoxanide on Echinococcus granulosus protoscoleces and metacestodes | Q44999194 |
| | Treatment of strongyloidiasis with mebendazole and its combination with thiabendazole | Q45001853 |
| | The safety, tolerability and pharmacokinetics of levamisole alone, levamisole plus ivermectin, and levamisole plus albendazole, and their efficacy against Onchocerca volvulus | Q45026603 |
| | Clinical observations on the treatment of hookworm, Ascaris and Trichuris infection with oxibendazole | Q45054944 |
| | Comparative efficacy of moxidectin and mebendazole against gastrointestinal nematodes in experimentally infected lambs | Q45222675 |
| | A double-blind controlled field trial of doxycycline and albendazole in combination for the treatment of bancroftian filariasis in India. | Q45784403 |
| | Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline. | Q45885125 |
| | Heme and blood-feeding parasites: friends or foes? | Q34393277 |
| | Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial | Q34427386 |
| | Nitazoxanide for the treatment of intestinal protozoan and helminthic infections in Mexico | Q34467413 |
| | In vitro and in vivo efficacies of mefloquine-based treatment against alveolar echinococcosis. | Q34529138 |
| | Evaluation of nitazoxanide for the treatment of disseminated cystic echinococcosis: report of five cases and literature review | Q34531388 |
| | A randomized trial of doxycycline for Mansonella perstans infection | Q34612544 |
| | Ocular onchocerciasis: current management and future prospects | Q34633609 |
| | Strongyloides stercoralis: a plea for action | Q34723461 |
| | Cyclooctadepsipeptides--a new class of anthelmintically active compounds | Q34727979 |
| | A randomized controlled pilot study of artesunate versus triclabendazole for human fascioliasis in central Vietnam | Q34761209 |
| | In vitro parasiticidal effect of Nitazoxanide against Echinococcus multilocularis metacestodes | Q34822604 |
| | Paromomycin | Q34864208 |
| | Myrrh and trematodoses in Egypt: an overview of safety, efficacy and effectiveness profiles. | Q34981312 |
| | Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans | Q35014094 |
| | Neurocysticercosis: an update. | Q35017750 |
| | Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis | Q35120602 |
| | The activity of dispiro peroxides against Fasciola hepatica | Q35175961 |
| | Schistosomiasis and soil-transmitted helminthiasis: common drugs for treatment and control | Q35680581 |
| | In vivo activity of aryl ozonides against Schistosoma species | Q35689350 |
| | In vitro and in vivo activities of synthetic trioxolanes against major human schistosome species | Q35758795 |
| | Chemotherapy for major food-borne trematodes: a review | Q35841575 |
| | Antischistosomal activities of mefloquine-related arylmethanols | Q36018841 |
| | In vitro and in vivo activity of 3-alkoxy-1,2-dioxolanes against Schistosoma mansoni | Q36088768 |
| | Doxycycline improves filarial lymphedema independent of active filarial infection: a randomized controlled trial. | Q36143298 |
| | Triclabendazole for the treatment of fascioliasis and paragonimiasis | Q36322074 |
| | Medical treatment of echinococcosis under the guidance of Good Clinical Practice (GCP/ICH). | Q36336202 |
| | Effect of combinations of marketed human anthelmintic drugs against Trichuris muris in vitro and in vivo | Q36499326 |
| | Metabolism and disposition of tribendimidine and its metabolites in healthy Chinese volunteers | Q36649179 |
| | Efficacy and safety of tribendimidine against Clonorchis sinensis | Q36656270 |
| | Development of an in vitro drug sensitivity assay for Trichuris muris first-stage larvae | Q36710433 |
| | Artemisinins for schistosomiasis and beyond. | Q36747308 |
| | Understanding triclabendazole resistance | Q36776091 |
| | In vitro and in vivo treatments of echinococcus protoscoleces and metacestodes with artemisinin and artemisinin derivatives | Q36870795 |
| | Salvage treatment with amphotericin B in progressive human alveolar echinococcosis | Q36880781 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 185-200 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | International Journal for Parasitology: Drugs and Drug Resistance | Q20181953 |
| P1476 | title | Repurposing drugs for the treatment and control of helminth infections | |
| P478 | volume | 4 | |